(Q35702158)

9 August 2017

1 reference

title

Mass treatment of onchocerciasis with ivermectin: should people with epilepsy and/or growth-retardation syndromes be excluded? (English)

1 reference

9 August 2017

0 references

0 references

Twum-Danso NA

1

1 reference

9 August 2017

language of work or name

1 reference

1 March 2004

1 reference

Annals of Tropical Medicine and Parasitology

9 August 2017

published in

1 reference

9 August 2017

volume

98

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

99-114

1 reference

Relationship Between Epilepsy and Tropical Diseases

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Prevalence of epilepsy in Kelibia, Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Prevalence and treatment of mental disorders and epilepsy in Zanzibar

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Ivermectin: A Potent New Antiparasitic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Anticonvulsant effects of ivermectin in genetically-epileptic chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Onchocerciasis, epilepsy and hyposexual dwarfism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Epilepsy in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Determining the prevalence of epilepsy in the semi-urban population of Nakuru, Kenya, comparing two independent methods not apparently used before in epilepsy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Epilepsy in a focus of onchocerciasis in Burkina Faso.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

High incidence of epilepsy related to onchocerciasis in West Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Global Campaign Against Epilepsy:the treatment gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Onchocerciasis and epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Improvement in seizures after ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Onchocerciasis and epilepsy in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

The biochemical basis of anthelmintic action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Modulation of monomethylhydrazine-induced seizures by ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Epilepsy, retarded growth and onchocerciasis, in two areas of different endemicity of onchocerciasis in Burundi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Prevalence of the epilepsies in Nigerian Africans: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Incidence and prevalence studies in epilepsy and their methodological problems: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Longitudinal study of lesions of the posterior segment in onchocerciasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Epilepsy in developing countries: a review of epidemiological, sociocultural, and treatment aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Transporter-mediated permeation of drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Community-based study of neurological disorders in rural central Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

A West African epilepsy focus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

The Nakalanga syndrome in Kabarole District, Western Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

Endocrine dysfunction in a Nakalanga dwarf

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349804225003208

10.1179/000349804225003208

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference